Trials / Completed
CompletedNCT04272567
Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension
Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients Undergoing Cesarean Section: a Randomized, Placebo-controlled Dose-finding Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 99 (actual)
- Sponsor
- General Hospital of Ningxia Medical University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the suitable infusion dose of norepinephrine for prophylaxis against post-spinal anesthesia hypotension.
Detailed description
Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylactic measures are not taken. Vasopressors has been highly recommended for routine prevention and/or treatment of post-spinal anesthesia hypotension. As a potential substitute drug for phenylephrine, norepinephrine has gradually been used in parturients undergoing cesarean section. There's some evidence that prophylactic infusion of norepinephrine could effectively reduce the incidence of post-spinal anesthesia hypotension in parturients undergoing cesarean section. But the ideal infusion dose of norepinephrine is still unknown. The purpose of this study is to investigate the suitable infusion dose of norepinephrine for prophylaxis against post-spinal anesthesia hypotension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Norepinephrine | Simultaneous with subarachnoid block, a bolus of 6μg norepinephrine was given followed by different infusion dose of norepinephrine. |
| DRUG | Normal saline | Simultaneous with subarachnoid block, a bolus of 1ml normal saline was given followed by normal saline infusion |
Timeline
- Start date
- 2020-03-28
- Primary completion
- 2020-06-30
- Completion
- 2020-06-30
- First posted
- 2020-02-17
- Last updated
- 2020-08-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04272567. Inclusion in this directory is not an endorsement.